Ken Griffin Axonics, Inc. Transaction History

Citadel Advisors LLC

$483 Billion
Q2 2024

A detailed history of Ken Griffin (Citadel Advisors LLC) transactions in Axonics, Inc. stock. As of the latest transaction made, Citadel Advisors LLC holds 5,400 shares of AXNX stock, worth $376,218. This represents 0.0% of its overall portfolio holdings.

Number of Shares

5,400

Previous 8,500 36.47%

Holding current value

$376,218

Previous $586,000 38.05%

% of portfolio

0.0%

Previous 0.0%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$66.47 - $69.65 $245,540 - $257,287	3,694 Added 20.11%	22,062 $1.48 Million
Q1 2024 May 15, 2024	SELL	$56.67 - $69.36 $3.76 Million - $4.6 Million	-66,350 Reduced 78.32%	18,368 $1.27 Million
Q4 2023 Feb 14, 2024	SELL	$49.38 - $63.75 $32.9 Million - $42.4 Million	-665,408 Reduced 88.71%	84,718 $5.27 Million
Q3 2023 Nov 14, 2023	BUY	$48.64 - $62.51 $16.9 Million - $21.8 Million	348,006 Added 86.54%	750,126 $42.1 Million
Q2 2023 Aug 14, 2023	BUY	$47.99 - $60.21 $5.51 Million - $6.91 Million	114,833 Added 39.97%	402,120 $20.3 Million
Q1 2023 May 15, 2023	SELL	$52.6 - $67.34 $12.5 Million - $16 Million	-238,065 Reduced 45.32%	287,287 $15.7 Million
Q4 2022 Feb 14, 2023	BUY	$59.56 - $76.6 $11.1 Million - $14.3 Million	186,650 Added 55.11%	525,352 $32.9 Million
Q3 2022 Nov 14, 2022	BUY	$57.96 - $78.12 $807,324 - $1.09 Million	13,929 Added 4.29%	338,702 $23.9 Million
Q2 2022 Aug 15, 2022	BUY	$39.5 - $64.42 $11.8 Million - $19.3 Million	299,886 Added 1204.99%	324,773 $18.4 Million
Q1 2022 May 16, 2022	SELL	$43.74 - $62.76 $13.2 Million - $19 Million	-302,919 Reduced 92.41%	24,887 $1.56 Million
Q4 2021 Feb 14, 2022	BUY	$50.01 - $73.35 $11.5 Million - $16.8 Million	229,711 Added 234.17%	327,806 $18.4 Million
Q3 2021 Nov 15, 2021	SELL	$59.21 - $78.66 $16.8 Million - $22.4 Million	-284,377 Reduced 74.35%	98,095 $6.39 Million
Q2 2021 Aug 16, 2021	SELL	$51.39 - $66.9 $19.8 Million - $25.8 Million	-385,767 Reduced 50.21%	382,472 $24.3 Million
Q1 2021 May 17, 2021	BUY	$49.14 - $59.89 $31.4 Million - $38.3 Million	639,485 Added 496.67%	768,239 $46 Million
Q4 2020 Feb 16, 2021	BUY	$42.19 - $51.5 $2.98 Million - $3.63 Million	70,540 Added 121.17%	128,754 $6.43 Million
Q3 2020 Nov 16, 2020	SELL	$35.33 - $51.04 $635,198 - $917,648	-17,979 Reduced 23.6%	58,214 $2.97 Million
Q2 2020 Aug 14, 2020	SELL	$22.91 - $39.83 $1.83 Million - $3.19 Million	-79,999 Reduced 51.22%	76,193 $2.68 Million
Q1 2020 May 15, 2020	SELL	$16.44 - $37.73 $5.45 Million - $12.5 Million	-331,791 Reduced 67.99%	156,192 $3.97 Million
Q4 2019 Feb 14, 2020	SELL	$19.57 - $28.96 $604,106 - $893,966	-30,869 Reduced 5.95%	487,983 $13.5 Million
Q3 2019 Nov 14, 2019	BUY	$26.92 - $42.41 $12.4 Million - $19.6 Million	461,538 Added 805.28%	518,852 $14 Million
Q2 2019 Aug 14, 2019	BUY	$18.54 - $40.97 $864,186 - $1.91 Million	46,612 Added 435.54%	57,314 $2.35 Million
Q1 2019 May 15, 2019	SELL	$13.32 - $24.35 $11,495 - $21,014	-863 Reduced 7.46%	10,702 $0
Q4 2018 Feb 14, 2019	BUY	$13.2 - $16.43 $152,658 - $190,012	11,565 New	11,565 $174,000

Others Institutions Holding AXNX

# of Institutions

241

Shares Held

42.8M

Call Options Held

73.7K

Put Options Held

230K

View Full List

About Axonics, Inc.

Ticker AXNX
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 49,123,600
Market Cap $3.42B
Description
Axonics, Inc., a medical technology company, engages in the development and commercialization of sacral neuromodulation (SNM) systems. The company's SNM systems are used to treat patients with overactive bladder, including urinary urge incontinence and urinary urgency frequency, as well as fecal incontinence and non-obstructive urinary retention...

More about AXNX

Track Ken Griffin's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.

Account